Skip to main content
Top
Published in: Clinical Orthopaedics and Related Research® 8/2008

01-08-2008 | Symposium: New Approaches to Allograft Transplantation

Quantification of Massive Allograft Healing with Dynamic Contrast Enhanced-MRI and Cone Beam-CT: A Pilot Study

Authors: Nicole Ehrhart, VMD, MS, Susan Kraft, DVM, PhD, David Conover, MS, Randy N. Rosier, MD, PhD, Edward M. Schwarz, PhD

Published in: Clinical Orthopaedics and Related Research® | Issue 8/2008

Login to get access

Abstract

Although massive allografts are widely used for reconstruction of critical defects in long bones caused by tumor or trauma, many will have inadequate long-term outcomes. Toward a tissue engineering solution to this problem, we developed experimental stem cell and gene therapy adjuvants that induce angiogenesis, osteogenesis, and remodeling of the structural allografts. We present data from pilot studies to show the utility of dynamic contrast enhanced MRI (DCE-MRI) to quantify vascularity after femoral osteotomy in a canine femur model and cone beam CT (CB-CT) to quantify bone volume in a patient after composite prosthetic-allograft reconstructive surgery. The results demonstrate our ability to suppress the artifacts generated by the metal implants required to secure massive allografts such that precise quantification of cortical bone revascularization (>10-fold increase at 3 weeks postoperatively) and new bone formation (accurate to about 193 μm3) around the graft can be performed longitudinally via DCE-MRI and CB-CT, respectively.
Literature
1.
go back to reference Ashton EA, McShane T, Evelhoch J. Inter-operator variability in perfusion assessment of tumors in MRI using automated AIF detection. LNCS. 2005;3749:451–458. Ashton EA, McShane T, Evelhoch J. Inter-operator variability in perfusion assessment of tumors in MRI using automated AIF detection. LNCS. 2005;3749:451–458.
2.
go back to reference Awad HA, Zhang X, Reynolds DG, Guldberg RE, O’Keefe RJ, Schwarz EM. Recent advances in gene delivery for structural bone allografts: a review. Tissue Eng. 2007;13:1973–1985.PubMedCrossRef Awad HA, Zhang X, Reynolds DG, Guldberg RE, O’Keefe RJ, Schwarz EM. Recent advances in gene delivery for structural bone allografts: a review. Tissue Eng. 2007;13:1973–1985.PubMedCrossRef
3.
go back to reference Berrey BH Jr, Lord CF, Gebhardt MC, Mankin HJ. Fractures of allografts: frequency, treatment, and end-results. J Bone Joint Surg Am. 1990;72:825–833.PubMed Berrey BH Jr, Lord CF, Gebhardt MC, Mankin HJ. Fractures of allografts: frequency, treatment, and end-results. J Bone Joint Surg Am. 1990;72:825–833.PubMed
4.
go back to reference Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine. 2002;27:2662–2673.PubMedCrossRef Boden SD, Kang J, Sandhu H, Heller JG. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine. 2002;27:2662–2673.PubMedCrossRef
5.
go back to reference Bos GD, Goldberg VM, Zika JM, Heiple KG, Powell AE. Immune responses of rats to frozen bone allografts. J Bone Joint Surg Am. 1983;65:239–246.PubMed Bos GD, Goldberg VM, Zika JM, Heiple KG, Powell AE. Immune responses of rats to frozen bone allografts. J Bone Joint Surg Am. 1983;65:239–246.PubMed
6.
go back to reference Brigman BE, Hornicek FJ, Gebhardt MC, Mankin HJ. Allografts about the knee in young patients with high-grade sarcoma. Clin Orthop Relat Res. 2004;421:232–239.PubMedCrossRef Brigman BE, Hornicek FJ, Gebhardt MC, Mankin HJ. Allografts about the knee in young patients with high-grade sarcoma. Clin Orthop Relat Res. 2004;421:232–239.PubMedCrossRef
7.
go back to reference Burkus JK, Sandhu HS, Gornet MF, Longley MC. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am. 2005;87:1205–1212.PubMedCrossRef Burkus JK, Sandhu HS, Gornet MF, Longley MC. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am. 2005;87:1205–1212.PubMedCrossRef
8.
9.
go back to reference Enneking WF, Campanacci DA. Retrieved human allografts: a clinicopathological study. J Bone Joint Surg Am. 2001;83:971–986.PubMed Enneking WF, Campanacci DA. Retrieved human allografts: a clinicopathological study. J Bone Joint Surg Am. 2001;83:971–986.PubMed
10.
go back to reference Enneking WF, Mindell ER. Observations on massive retrieved human allografts. J Bone Joint Surg Am. 1991;73:1123–1142.PubMed Enneking WF, Mindell ER. Observations on massive retrieved human allografts. J Bone Joint Surg Am. 1991;73:1123–1142.PubMed
11.
go back to reference Ernstberger T, Heidrich G, Bruening T, Krefft S, Buchhorn G, Klinger HM. The interobserver-validated relevance of intervertebral spacer materials in MRI artifacting. Eur Spine J. 2007;16:179–185.PubMedCrossRef Ernstberger T, Heidrich G, Bruening T, Krefft S, Buchhorn G, Klinger HM. The interobserver-validated relevance of intervertebral spacer materials in MRI artifacting. Eur Spine J. 2007;16:179–185.PubMedCrossRef
12.
go back to reference Fiorellini JP, Howell TH, Cochran D, Malmquist J, Lilly LC, Spagnoli D, Toljanic J, Jones A, Nevins M. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol. 2005;76:605–613.PubMedCrossRef Fiorellini JP, Howell TH, Cochran D, Malmquist J, Lilly LC, Spagnoli D, Toljanic J, Jones A, Nevins M. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol. 2005;76:605–613.PubMedCrossRef
13.
go back to reference Friedlaender GE. Bone grafts. The basic science rationale for clinical applications. J Bone Joint Surg Am 1987;69–5:786–90. Friedlaender GE. Bone grafts. The basic science rationale for clinical applications. J Bone Joint Surg Am 1987;69–5:786–90.
14.
15.
go back to reference Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84:2123–2134.PubMedCrossRef Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84:2123–2134.PubMedCrossRef
16.
go back to reference Ito H, Koefoed M, Tiyapatanaputi P, Gromov K, Goater JJ, Carmouche J, Zhang X, Rubery PT, Rabinowitz J, Samulski RJ, Nakamura T, Soballe K, O’Keefe RJ, Boyce BF, Schwarz EM. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med. 2005;11:291–297.PubMedCrossRef Ito H, Koefoed M, Tiyapatanaputi P, Gromov K, Goater JJ, Carmouche J, Zhang X, Rubery PT, Rabinowitz J, Samulski RJ, Nakamura T, Soballe K, O’Keefe RJ, Boyce BF, Schwarz EM. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med. 2005;11:291–297.PubMedCrossRef
17.
go back to reference Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX, Pollak AN, Golden JD, Valentin-Opran A. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects: a randomized, controlled trial. J Bone Joint Surg Am. 2006;88:1431–1441.PubMedCrossRef Jones AL, Bucholz RW, Bosse MJ, Mirza SK, Lyon TR, Webb LX, Pollak AN, Golden JD, Valentin-Opran A. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects: a randomized, controlled trial. J Bone Joint Surg Am. 2006;88:1431–1441.PubMedCrossRef
18.
go back to reference Koefoed M, Ito H, Gromov K, Reynolds DG, Awad HA, Rubery PT, Ulrich-Vinther M, Soballe K, Guldberg RE, Lin AS, O’Keefe RJ, Zhang X, Schwarz EM. Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther. 2005;12:212–218.PubMedCrossRef Koefoed M, Ito H, Gromov K, Reynolds DG, Awad HA, Rubery PT, Ulrich-Vinther M, Soballe K, Guldberg RE, Lin AS, O’Keefe RJ, Zhang X, Schwarz EM. Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther. 2005;12:212–218.PubMedCrossRef
19.
go back to reference Looney RJ, Boyd A, Totterman S, Seo GS, Tamez-Pena J, Campbell D, Novotny L, Olcott C, Martell J, Hayes FA, O’Keefe RJ, Schwarz EM. Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wear. Arthritis Res. 2002;4:59–63.PubMedCrossRef Looney RJ, Boyd A, Totterman S, Seo GS, Tamez-Pena J, Campbell D, Novotny L, Olcott C, Martell J, Hayes FA, O’Keefe RJ, Schwarz EM. Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wear. Arthritis Res. 2002;4:59–63.PubMedCrossRef
20.
go back to reference Lord CF, Gebhardt MC, Tomford WW, Mankin HJ. Infection in bone allografts: incidence, nature, and treatment. J Bone Joint Surg Am. 1988;70:369–376.PubMed Lord CF, Gebhardt MC, Tomford WW, Mankin HJ. Infection in bone allografts: incidence, nature, and treatment. J Bone Joint Surg Am. 1988;70:369–376.PubMed
21.
go back to reference Matejovsky Z Jr, Matejovsky Z, Kofranek I. Massive allografts in tumour surgery. Int Orthop. 2006;30:478–483.PubMedCrossRef Matejovsky Z Jr, Matejovsky Z, Kofranek I. Massive allografts in tumour surgery. Int Orthop. 2006;30:478–483.PubMedCrossRef
22.
go back to reference Pluhar GE, Manley PA, Heiner JP, Vanderby R Jr, Seeherman HJ, Markel MD. The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model. J Orthop Res. 2001;19:308–317.PubMedCrossRef Pluhar GE, Manley PA, Heiner JP, Vanderby R Jr, Seeherman HJ, Markel MD. The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model. J Orthop Res. 2001;19:308–317.PubMedCrossRef
23.
go back to reference Ramos-Cabrer P, van Duynhoven JP, Van der Toorn A, Nicolay K. MRI of hip prostheses using single-point methods: in vitro studies towards the artifact-free imaging of individuals with metal implants. Magn Reson Imaging. 2004;22:1097–1103.PubMedCrossRef Ramos-Cabrer P, van Duynhoven JP, Van der Toorn A, Nicolay K. MRI of hip prostheses using single-point methods: in vitro studies towards the artifact-free imaging of individuals with metal implants. Magn Reson Imaging. 2004;22:1097–1103.PubMedCrossRef
24.
go back to reference Reynolds DG, Hock C, Shaikh S, Jacobson J, Zhang X, Rubery PT, Beck CA, O’Keefe RJ, Lerner AL, Schwarz EM, Awad HA. Micro-computed tomography prediction of biomechanical strength in murine structural bone grafts. J Biomech. 2007;40:3178–3186.PubMedCrossRef Reynolds DG, Hock C, Shaikh S, Jacobson J, Zhang X, Rubery PT, Beck CA, O’Keefe RJ, Lerner AL, Schwarz EM, Awad HA. Micro-computed tomography prediction of biomechanical strength in murine structural bone grafts. J Biomech. 2007;40:3178–3186.PubMedCrossRef
25.
go back to reference Schwartz Z, Somers A, Mellonig JT, Carnes DL Jr, Wozney JM, Dean DD, Cochran DL, Boyan BD. Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material. J Periodontol. 1998;69:1337–1345.PubMed Schwartz Z, Somers A, Mellonig JT, Carnes DL Jr, Wozney JM, Dean DD, Cochran DL, Boyan BD. Addition of human recombinant bone morphogenetic protein-2 to inactive commercial human demineralized freeze-dried bone allograft makes an effective composite bone inductive implant material. J Periodontol. 1998;69:1337–1345.PubMed
26.
go back to reference Stevenson S, Emery SE, Goldberg VM. Factors affecting bone graft incorporation. Clin Orthop Relat Res. 1996;324:66–74.PubMedCrossRef Stevenson S, Emery SE, Goldberg VM. Factors affecting bone graft incorporation. Clin Orthop Relat Res. 1996;324:66–74.PubMedCrossRef
27.
go back to reference Stevenson S, Li XQ, Davy DT, Klein L, Goldberg VM. Critical biological determinants of incorporation of non-vascularized cortical bone grafts: quantification of a complex process and structure. J Bone Joint Surg Am. 1997;79:1–16.PubMedCrossRef Stevenson S, Li XQ, Davy DT, Klein L, Goldberg VM. Critical biological determinants of incorporation of non-vascularized cortical bone grafts: quantification of a complex process and structure. J Bone Joint Surg Am. 1997;79:1–16.PubMedCrossRef
28.
go back to reference Tsuchida H, Hashimoto J, Crawford E, Manske P, Lou J. Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats. J Orthop Res. 2003;21:44–53.PubMedCrossRef Tsuchida H, Hashimoto J, Crawford E, Manske P, Lou J. Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats. J Orthop Res. 2003;21:44–53.PubMedCrossRef
29.
go back to reference Walker-Samuel S, Leach MO, Collins DJ. Reference tissue quantification of DCE-MRI data without a contrast agent calibration. Phys Med Biol. 2007;52:589–601.PubMedCrossRef Walker-Samuel S, Leach MO, Collins DJ. Reference tissue quantification of DCE-MRI data without a contrast agent calibration. Phys Med Biol. 2007;52:589–601.PubMedCrossRef
30.
go back to reference Wang J, Temple HT, Pitcher JD, Mounasamy V, Malinin TI, Scully SP. Salvage of failed massive allograft reconstruction with endoprosthesis. Clin Orthop Relat Res. 2006;443:296–301.PubMedCrossRef Wang J, Temple HT, Pitcher JD, Mounasamy V, Malinin TI, Scully SP. Salvage of failed massive allograft reconstruction with endoprosthesis. Clin Orthop Relat Res. 2006;443:296–301.PubMedCrossRef
31.
go back to reference Wheeler DL, Enneking WF. Allograft bone decreases in strength in vivo over time. Clin Orthop Relat Res. 2005;435:36–42.PubMedCrossRef Wheeler DL, Enneking WF. Allograft bone decreases in strength in vivo over time. Clin Orthop Relat Res. 2005;435:36–42.PubMedCrossRef
32.
go back to reference Xie C, Reynolds D, Awad H, Rubery PT, Pelled G, Gazit D, Guldberg RE, Schwarz EM, O’Keefe RJ, Zhang X. Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering. Tissue Eng. 2007;13:435–445.PubMedCrossRef Xie C, Reynolds D, Awad H, Rubery PT, Pelled G, Gazit D, Guldberg RE, Schwarz EM, O’Keefe RJ, Zhang X. Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering. Tissue Eng. 2007;13:435–445.PubMedCrossRef
33.
go back to reference Zabka AG, Pluhar GE, Edwards RB 3rd, Manley PA, Hayashi K, Heiner JP, Kalscheur VL, Seeherman HJ, Markel. Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: a comparison of rhBMP-2, cancellous bone graft, and absorbable collagen sponge. J Orthop Res. 2001;19:318–327.PubMedCrossRef Zabka AG, Pluhar GE, Edwards RB 3rd, Manley PA, Hayashi K, Heiner JP, Kalscheur VL, Seeherman HJ, Markel. Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: a comparison of rhBMP-2, cancellous bone graft, and absorbable collagen sponge. J Orthop Res. 2001;19:318–327.PubMedCrossRef
34.
go back to reference Zhang X, Xie C, Lin AS, Ito H, Awad H, Lieberman JR, Rubery PT, Schwarz EM, O’Keefe RJ, Guldberg RE. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res. 2005;20:2124–2137.PubMedCrossRef Zhang X, Xie C, Lin AS, Ito H, Awad H, Lieberman JR, Rubery PT, Schwarz EM, O’Keefe RJ, Guldberg RE. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res. 2005;20:2124–2137.PubMedCrossRef
Metadata
Title
Quantification of Massive Allograft Healing with Dynamic Contrast Enhanced-MRI and Cone Beam-CT: A Pilot Study
Authors
Nicole Ehrhart, VMD, MS
Susan Kraft, DVM, PhD
David Conover, MS
Randy N. Rosier, MD, PhD
Edward M. Schwarz, PhD
Publication date
01-08-2008
Publisher
Springer-Verlag
Published in
Clinical Orthopaedics and Related Research® / Issue 8/2008
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-008-0293-5

Other articles of this Issue 8/2008

Clinical Orthopaedics and Related Research® 8/2008 Go to the issue

Symposium: New Approaches to Allograft Transplantation

Radioprotection of Tendon Tissue via Crosslinking and Free Radical Scavenging